Skip to main content
    O

    Omada Health, Inc. Common Stock (OMDA)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $14.08
    -0.41 (-2.83%)

    Market Cap: $898.93M

    Last updated: Nov 17, 2026 at 4:33 PM ET

    Omada Health, Inc. Common Stock (OMDA) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Omada Health, Inc. Common Stock (OMDA) has a market cap of $898.93M and an enterprise value of $655.78M. Revenue grew 43.34% over the last 12 months from the 12 months before. Its share count is up 6.66% from a year earlier.

    Total Valuation

    Enterprise value is 27.05% below the market cap, as cash exceeds debt.

    Market Cap$898.93M
    Enterprise Value$655.78M
    Latest price (Nov 17, 2026)$14.08

    Key Dates

    The next earnings report is expected on Mar 3, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 3, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 3.04% in the quarter ended Sep 30, 2026 and grew 5.03% a year over 2 years.

    Shares Outstanding61.50M
    Shares Change (YoY)+6.66%
    Shares Change (QoQ)+3.04%
    Share Count Growth (2Y CAGR)+5.03%

    Valuation Ratios

    Sales and book value multiples are 2.6x and 3.2x.

    P/E Ratio35.9x
    Forward P/E109.0x
    P/S Ratio2.6x
    Forward P/S2.6x
    P/B Ratio3.2x
    P/TBV Ratio3.3x
    P/FCF Ratio38.5x
    P/OCF Ratio31.3x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 27.7x free cash flow.

    EV / Earnings46.7x
    EV / Sales2.0x
    EV / FCF27.7x

    Price Statistics

    The stock is down 29.78% over 52 weeks and trades 25.78% below its 50-day average.

    Beta (1Y)1.10
    52-Week Change-29.78%
    1-Month Change-22.04%
    3-Month Change-42.46%
    6-Month Change-15.18%
    Total Return (1Y)-29.78%
    Return vs SPY (1Y)-37.49%
    Max Drawdown (1Y)-43.78%
    Sharpe Ratio (1Y)-0.46
    Correlation with SPY (1Y)0.23
    50-Day Average$18.97
    200-Day Average$17.71
    52-Week Range$10.28 to $25.45
    RSI (14 Days)29.4
    Average Volume (20 Days)1.30M

    Financial Position

    Current assets cover 4.18x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio4.18x
    Quick Ratio4.11x
    Debt / Equity0.00x
    Interest Coverage22.37x

    Returns and Efficiency

    Return on equity is 5.14% and return on assets is 4.03% over the last 12 months.

    Return on Equity (ROE)5.14%
    Return on Assets (ROA)4.03%
    Asset Turnover1.05x
    Inventory Turnover21.69x
    Receivables Turnover6.36x
    Cash Conversion Cycle36 days

    Taxes

    Income tax took 0.00% of pretax income over the last 12 months.

    Income Tax (TTM)$0
    Effective Tax Rate0.00%

    Scores

    OMDA has an Altman Z-Score of 6.94, in the safe zone above 2.99, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.

    Altman Z-Score6.94
    Altman Z ZoneSafe
    Piotroski F-Score5 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $333.04M over the last 12 months.

    Revenue$333.04M
    Revenue Growth (YoY)+43.34%
    Gross Profit$235.42M
    Operating Income$6.87M
    Pretax Income$14.03M
    Net Income$14.03M
    EBITDA$17.88M
    Reported EPS (TTM)$0.39

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 78.37% of the $348.54M in total assets.

    Cash and Equivalents$243.15M
    Total Debt$0
    Net Cash$243.15M
    Net Cash Per Share$3.95
    Working Capital$239.68M
    Shareholder Equity$273.16M
    Book Value Per Share$4.44
    Tangible Book Value$258.82M
    Tangible Book Per Share$4.21
    Total Assets$348.54M
    Total Liabilities$75.38M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $6.20M of capital spending, operating cash flow left $22.49M of free cash flow.

    Operating Cash Flow$28.69M
    Capital Expenditures$6.20M
    Free Cash Flow$22.49M
    FCF Per Share$0.37
    Depreciation and Amortization$9.99M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 2.06%.

    Gross Margin70.69%
    Operating Margin2.06%
    Pretax Margin4.21%
    Net Margin4.21%
    EBITDA Margin5.37%
    FCF Margin6.75%

    Growth

    Revenue grew 42.89% a year over 3 years.

    Revenue Growth (3Y CAGR)+42.89%
    Book Value Per Share Growth (2Y CAGR)+48.83%
    Tangible Book Per Share Growth (2Y CAGR)+60.35%

    Revenue and profit by year

    Dividends and Yields

    OMDA does not pay a dividend. Its free cash flow yield is 2.60%.

    Earnings Yield2.79%
    FCF Yield2.60%
    Buyback Yield0.00%
    Shareholder Yield0.00%

    Peer Position

    Against 7 similar companies, OMDA has the 3rd highest P/E.

    P/E Ratio35.9x vs 34.8x median
    P/S Ratio2.6x vs 1.5x median
    Revenue Growth (Trailing 4 Quarters, YoY)+43.34% vs +11.38% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About OMDA

    What is OMDA's market cap?

    Omada Health, Inc. Common Stock has a market cap of $898.93M. Its enterprise value, which adds debt and subtracts cash, is $655.78M.

    What is OMDA's P/E ratio?

    Omada Health, Inc. Common Stock has a trailing P/E ratio of 35.9x and a forward P/E of 109.0x.

    How many shares of OMDA are outstanding?

    Omada Health, Inc. Common Stock has 61.50M shares outstanding. The count is up 6.66% from a year earlier.

    Does OMDA pay a dividend?

    No. Omada Health, Inc. Common Stock does not pay a dividend.

    How much debt does OMDA have?

    Omada Health, Inc. Common Stock has $0 of total debt and $243.15M of cash and equivalents, a net cash position of $243.15M.